Microvascular CE / CME

Home About Contact Add Activities Provider Login

	Are You Seeing the Whole Picture? Test Your Skills for Intensifying Therapy in Patients with Type 2 Diabetes The management of type 2 diabetes (T2D) has evolved rapidly with new agents and changing recommendations. Do you see the whole picture when selecting therapy for your patients? Engage in this interactive clinical case challenge to see whether your treatment selection aligns with guideline recommendations and account for cardiovascular disease risks, patient-centric factors, and weight management. ACHL
	Improving Selection and Utilization of Continuous Glucose Monitors (CGM) for People with Diabetes Self-monitoring of blood glucose (BG) levels is critical to daily self-management for people with diabetes. Studies have shown that intensive insulin regimens and BG control corresponded with better glycemic control have resulted in a significant decrease in the microvascular complications of diabetes. Because CGM is still an evolving technology, both clinicians and patients would benefit from engaging, interactive, and evidence-based education to improve the utilization of these tools. Dannemiller

Are You Seeing the Whole Picture? Test Your Skills for Intensifying Therapy in Patients with Type 2 Diabetes

The management of type 2 diabetes (T2D) has evolved rapidly with new agents and changing recommendations. Do you see the whole picture when selecting therapy for your patients? Engage in this interactive clinical case challenge to see whether your treatment selection aligns with guideline recommendations and account for cardiovascular disease risks, patient-centric factors, and weight management.
ACHL

Improving Selection and Utilization of Continuous Glucose Monitors (CGM) for People with Diabetes

Self-monitoring of blood glucose (BG) levels is critical to daily self-management for people with diabetes. Studies have shown that intensive insulin regimens and BG control corresponded with better glycemic control have resulted in a significant decrease in the microvascular complications of diabetes. Because CGM is still an evolving technology, both clinicians and patients would benefit from engaging, interactive, and evidence-based education to improve the utilization of these tools.
Dannemiller

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map